Melichar, B., & Mickisch, G. (2013). A multinational phase II trial of bevacizumab with low-dose interferon-alpha 2a as first-line treatment of metastatic renal cell carcinoma: BEVLiN. Annals of oncology, 24(9), .
Chicago-Zitierstil (17. Ausg.)Melichar, Bohuslav, und Gerald Mickisch. "A Multinational Phase II Trial of Bevacizumab with Low-dose Interferon-alpha 2a as First-line Treatment of Metastatic Renal Cell Carcinoma: BEVLiN." Annals of Oncology 24, no. 9 (2013).
MLA-Zitierstil (9. Ausg.)Melichar, Bohuslav, und Gerald Mickisch. "A Multinational Phase II Trial of Bevacizumab with Low-dose Interferon-alpha 2a as First-line Treatment of Metastatic Renal Cell Carcinoma: BEVLiN." Annals of Oncology, vol. 24, no. 9, 2013.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.